GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF
This invention relates to a novel compound which is a glycogen phosphorylase inhibitor and its use in the treatment of diabetes and other conditions associated therewith. The invention further relates to a pharmaceutical composition containing the compoun
-
Page/Page column 9; 21-22
(2009/05/29)
Arylformamidines with Antinociceptive Properties
A series of formamidines structurally related to clondine were synthesized and investigated as potential nonopiate analgesics.Several of these compounds showed potent analgesic activity (ED50 on HCl writhing 1.0 mg/kg) with low potential for hypotensive effects.A qualitative description of the structure-activity relationship of this series reveals that the 2,4- and 2,6-dimethylphenyl compounds are more potent analgesics than are the corresponding dichlorophenyl compounds.
Gall, M.,McCall, J. M.,TenBrink, R. E.,VonVoigtlander, P. F.,Mohrland, J. S.
p. 1816 - 1820
(2007/10/02)
More Articles about upstream products of 114886-15-6